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Abstract
The preparation and full NMR (1H,13C and 31p) characterisation of three R3PAu(2mba)
complexes, where R Et, Ph and Cy, and 2mba is the anion derived from 2-mercaptobenzoic acid
is reported. An interesting solvent dependence in the H spectra is rationalised in terms of
competing intra- and inter-molecular hydrogen bonding. An X-ray analysis of the [Ph3PAu(2mba)]
species reveals a linear P--Au--S arrangement and association in the lattice via the familar
carboxylic acid dimer motif. The in vitro cytotoxicity against seven human tumour lines is also
described. The complexes display moderate to very high activity. Particularly noteworthy is their
greater activity against the H226 cell line (non-small cell lung cancer) compared with that displayed
by a range of cytotoxic drugs.
Introduction
The use of gold complexes in the treatment of rheumatoid arthritis is well known [1-3]. Two
classes of complexes are used in this context, namely, polymeric, water soluble gold thiolates such
as myocrisin (sodium aurothiomalate) and solganol (aurothioglucose) as well as monomeric,
lipophilic auranofin ([(1-thi--D-gucpyranse-2346-tetraacetat-s)(triethyphsphine)gd())
Given their clinical use, a logical extension of the study of gold complexes is an exploration of their
potential use as anti-tumour agents [e.g. 1-3]. As a continuation of a program investigating the anti-
tumour activity of phosphinegold(I) thiolates [4,5], i.e. complexes containing the P--Au---S
arrangement as found in auranofin, the in vitro cytotoxicity of three R3PAu(2mba) complexes is
reported where R Et, Ph and Cy, and 2mba is the anion derived from 2-mercaptobenzoic acid.
The preparation of these complexes has been reported in the patent [6,7] and chemical literature
[8], and the crystal structure determination of the R Cy complex is also known [8].
Experimental
General
Analytical grade solvents were used without further purification. 1H (and 1H-1H COSY), 13C
and 31p NMR spectra were recorded on a Varian Gemini 2000 spectrometer operating at 300.145,
75.479 and 121.501 MHz, respectively. 1H-13C HSQC and HMBC 2D experiments were measured
on a Varian INOVA NMR spectrometer operating at 599.952 and 150.873 MHz for 1H and 13C NMR,
respectively. Electrospray mass spectra were obtained from methanol or ethanol solutions (NaOMe
was added in the case of R Ph and Cy (in-ve mode) in order to aid ionisation). Samples were
injected into a Finagan LCQ mass spectrometer via direct infusion using a syringe pump. Nitrogen
was used as the drying and nebulising gas. Elemental analyses were performed by Chemical and
Micro Analytical Services Pty Ltd (Belmont, Victoria).
Preparations
The R3PAuCI precursors were prepared according to the literature method [9] and 2-
mercaptobenzoic acid (2mbaH) was purchased from Fluka. The three R3PAu(2mba) complexes
were prepared using a similar procedure in each case. To a stirred ethanol solution (20 ml) of
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R3PAuCI (ca 500 mg) was added an aqueous ethanolic solution (20 ml) containing equimolar
quantities of 2mbaH and KOH. The solution was stirred at room temperature for h, the solvent
evaporated off and the residue recrystallised from acetone solution in each case.
[Et3PAu(2mba)]: Yellow crystals, Yield 82 %, m. pt 109- 110C. Found C, 33.23; H, 4.24.
C13H20AuO2PS requires, C, 33.34; H, 4.30.
[Ph3PAu(2mba)]: Yellow crystals, Yield 83 %, mo pt 157.5- 159C. Found C, 49.18; H, 3.27.
C25H20AuO2PS requires, C, 49.03; H, 3.29. Crystals suitable for X-ray crystallography were grown
from the slow evaporation and cooling of a hot ethanol solution of the complex.
[Cy3PAu(2mba)]: Colourless crystals, Yield 81%, m. pt 170- 171C. Found C, 47.68; H, 6.22.
C25H38AuO2PS requires, C, 47.62; H, 6.07.
Crystallography for [Ph,PAu(2mba)]
Intensity data for a yellow crystal (0.13 x 0.18 x 0.34 mm) were measured at room temperature
on a Rigoaku AFC6R diffractometer fitted with MoKo radiation (graphite monochromator, X
0.71073 A) using the o:2e scan technique so that emax was 25.0. No decomposition of the crystal
occurred during the data collection, the data set was corrected for Lorentz and polarization effects
[10] and for absorption employing an empirical procedure [11] such that the minimum and maximum
transmission factors were 0.352 and 1, respectively. A total of 4151 data (3942 unique) were
collected and of these, 2792 that satisfied the I_> 3.0c(/) criterion were used in the subsequent
analysis.
TABLE 1. Fractional atomic coordinates for [Ph3PAu(2mba)]
Atom x y z
A u 0.09236(4) 0.29464(4) 0.35885(6)
S(2) 0.3043(3) 0.3111(3) 0.4747(4)
P(1) -0.1107(3) 0.2895(3) 0.2216(3)
O(1) 0.1380(7) 0.0677(7) 0.488(1)
0(2) 0.0701 (8) 0.0898(7) 0.697(1)
C(1) 0.271(1) 0.204(1) 0.738(1)
C(1’) 0.154(1) 0.115(1) 0.628(2)
C(2) 0.3399(9) 0.2889(9) 0.677(1
C(3) 0.452(1 0.367(1 0.796(2)
C(4) 0.492(1 0.357(1 0.958(2)
C(5) 0.423(1) 0.273(1) 1.011(2)
C(6) 0.313(1 0.200(1 0.902(1
C(11) -0.1964(9) 0.1640(9) 0.050(1)
C(12) -0.128(1) 0.103(1) -0.017(1)
C(13) -0.189(1 0.008(1 -0.143(1
C(14) -0.321 (1) -0.027(1 -0.208(1
C(15) -0.389(1) 0.034(1) -0.141(1)
C(16) -0.325(1) 0.1288(9) -0.014(1)
C(21) -0.1212(9) 0.4173(9) 0.141(1)
C(22) -0.189(1) 0.416(1) -0.018(1)
C(23) -0.191(1) 0.519(1) -0.070(1)
C(24) -0.127(1) 0.623(1) 0.034(2)
C(25) -0.057(1) 0.626(1) 0.195(2)
C(26) -0.053(1) 0.525(1) 0.247(1)
C(31) -0.2111 (8) 0.2808(9) 0.348(1
C(32) -0.273(1 0.3638(9) 0.374(1
C(33) -0.350(1) 0.347(1) 0.469(1)
C(34) -0.365(1 0.251 (1) 0.532(1
C(35) -0.304(1) 0.168(1) 0.508(2)
C(36) -0.226(1) 0.184(1) 0.417(2)
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data: C5H20AuO2PS, M= 612.4, triclinic, space group P, a 11 541(8) A, b 12.081(8)
c 8.793(4) A, o 97.86(5), I 107.72(5), y 102.51 (6), V 1112(1") A3, Z 2, Dcalc 1.828
g cm"3, F(000) 592, 68.19 cm-1.
The structure was solved by direct-methods [12] and refined by a full-matrix least-squares
procedure based on F [10]. The non-hydrogen atoms were refined with anisotropic displacement
parameters and hydrogen atoms were included in the model in their calculated positions (C-H 0.97
A). The refinement was continued until convergence with sigma weights when R 0.044 and Rw
0.042. The maximum residual in the final difference map was 0.87 e ,&,-3. Fractional atomic
coordinates are listed in Table and the numbering scheme employed is shown in Figure 3 which
was drawn with ORTEP [13] at 50 % probability ellipsoids. Data manipulation was performed with
the teXsan program [10] installed on an Iris Indigo workstation. Other crystallographic details,
comprising fractional atomic coordinates for all atoms, thermal parameters, and all bond distances
and angles (in CIF format) have been deposited at the Cambridge Crystallographic Data Centre with
deposition number: 103334. Tables of observed and calculated structure factors are available on
request (ERTT).
In vitro screening
The standard growth medium RPMI 1640 and fetal calf serum (FCS) were obtained from Life
technologies (Paisley, Scotland). Sulforhodamine B (SRB), DMSO, penicillin and streptomycin
were obtained from Sigma (St Louis MO, USA), trichloroacetic and acetic acid from Baker BV
(Deventer, NL) and PBS from NPBI BV (Emmer-Compascuum, NL).
The test and reference compounds were dissolved to a concentration of 238095 ng/ml in full
medium, by 21 fold dilution of a DMSO solution which contained mg compound/200 #1. DMSO
was used as the solvent owing to poor solubility in ethanol. Further, the [Cy3PAu(2mba)] complex
was heated at 37C for h to effect solubility. Cytotoxicity was estimated by the microculture SRB
test [14]. On day 0, 150 #1 trypsinised tumour cells (1500- 2000 cells/well) were plated in 96 wells
flatbottom microtiter plates (falcon 3072, BD). The plates were preincubated for 48 h at 37C, 8.5 %
CO2 to allow the cells to adhere. On day 2, a three fold dilution sequence of ten steps was made in
full medium, starting with the 238095 ng/ml stock solution. Every dilution was used in
quadruplicate by adding 50 #1 to a column of four wells. This results in a highest concentration of
59523 ng/ml present in column 12. Column 2 was used for the blank. To column phosphate
buffered saline (PBS) was added to diminish interfering evaporation. On day 7, the incubation was
terminated by washing the plate twice with PBS. Subsequently, the cells were fixed with 10 %
trichloroacetic acid in PBS and placed at 4C for h. After five washings with tap water, the cells
were stained for at least 15 minutes with 0.4 % SRB dissolved in 1% acetic acid. After staining, the
cells were washed with 1% acetic acid to remove unbound stain. The plates were air dried and the
bound stain was dissolved in 150 1 10mM Tris-base. The absorbance was read at 540 nm using an
automated microplate reader (Labsystems Multiskan MS). Data were used for the construction of
concentration-response curves and determination of ID50 values by use of Deltasoft 3 software.
The following human tumour cell lines were used: MCF7 (breast cancer), EVSA-T (breast
cancer), WlDR (colon cancer), IGROV (ovarian cancer), M19 MEL (melanoma), A498 (renal cancer)
and H226 (non-small cell lung cancer). The WIDR, IGROV, M19 MEL, A498 and H226 cell lines are
found on the currently used anti-cancer screening panel of the National Cancer Institute, USA [15].
The MCF7 cell line is estrogen receptor (ER)+/progesterone receptor (PgR)+ and the cell line
EVSA-T is (ER)-/(PgR)-.
Prior to the experiments a mycoplasma test was performed on all the cell lines and found to
be negative. All cell lines were maintained in a continuous logarithmic culture in RPMI 1640
medium with Hepes and phenol red. The medium was supplemented with 10 % FCS, penicillin
100 IU/ml streptomycin 100 l.tg/ml. The cells were mildly trypsinised for passage and for use in the
experiments.
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TABLE 2. 1H NMR spectra (5 in ppm, coupling constants, in Hertz, are given in parentheses)
recorded in CDCI3 and DMSO-d6 solutions for 2mbaH and R3PAu(2mba). Abbreviations: d
doublet, triplet, dd= doublet of doublets, dt doublet of triplets, dq doublet of quartets, dtt
doublet of triplet of triplets, br broad, u unobserved. The atom lables for the thiol/thiolate is
shown in the scheme. The labels o to 5 refer to the nuclei of the phosphine ligands.
02H
SH
6
5
2mbaH* R Et R Ph R Cy
CDCI3 DMSO-d6 CDCI3 DMSO-d6 CDCI3 DMSO-d6 CDCI3 DMSO-d6
H4
H5
H6
OH
(P) Hc
H
7.31 dd 7.49 dd 7.50 dd 7.65 dd 7.74 dd 7.76 d-br 7.65 dd 7.66 d-br
(7.8, 1.2) (8.1, 0.9) (7.7, 1.4) (8.1, 1.2) (7.8, 1.2) (7.5) (7.6, 1.8) (7.8)
7.35 ddd 7.35 ddd 7.38 ddd 7.11 ddd 7.30 ddd 7.13 dd- br 7.28 ddd 7.10 ddd
(7.5, 7.5, (7.8, 7.8, (7.4, 7.4, (7.6, 7.6, (7.5, 7.5, (7.2) (7.5, 7.5, (7.6, 7.6,
1.4) 1.7) 1.6) 1.6) 1.8) 1.5) 1.5)
7.10 ddd 7.16 ddd 7.19 ddd 6.95 ddd 7.20 ddd 6.99 dd- 7.17 ddd 6.95 ddd
br
(7.4) (7.5, 7.5, (7.5, 7.5, (7.7, 7.7, (7.4, 7.4, (8.1, 8.1,
1.2) 1.1) 1.3) 1.3) 1.5)
8.12 dd 7.91 dd 8.30 dd 7.34 dd 8.32 dd 7.38 dd
([.8, 1.8) (8.0, 1.4) (7.5, 1.2) (7.5, 1.5) (8.0, 1.7) (7.4, 1.4)
u 13.01 br u 12.58 br 13.39 br 12.72 br
1.83 dq b 1.92 dq b
(10.1, 7.4) (10.2, 7.5)
1.17 dt c 1.11 dt c 7.43-7.49 7.49-7.56
(18.9, 7.7) (18.7, 7.7) rn m
Hy 7.43-7.49 7.54-7.58
m m
(7.5, 7.5, (7.6, 7.6,
.5) .5)
8.32 dd 7.36 dd
(7.8, 1.6) (7.8, 1.8)
13.49 br 12.50 br
1.98 dt-br a 2.17 dtt a
(10.8,. (9.5, 12.0,
13.4) 3.0)
1.84d-bre 1.78d-bre
(12.6) (12.3)
1.28 m a 1.33 dtt a
(12,.6, 12.6)
1.90d-bre 1.95d-bre
(10.2) (10.8)
1.39 m a 1.42 dtt a
(12.6) (11.4,
12.3, 3.9)
H5 7.50-7.54 7.58-7.62 1.72 d-br e 1.65 d-br e
m m (11.4) (12.0)
1.20 m a 1.21 dtt a
(12.6,
12.6, 3.2) a, 3JHa-
He), HI (where appropriate): (2JHa.He, 3JHa.Ha), H., (where appropriate): (2JHa.He, 3JHa.Ha, 3JHa.He), HS
(where appropriate): (2JHa.He, 3JHa.Ha, 3JHa.He).
b (2jH.p 3jR.H).
c (3jH.p 3jR.H).
SH: 4.61 sharp (CDCI3), 5.33 broad (DMSO-dT).
Results and Discussion
The three R3PAu(2mba), R Et, Ph and Cy, complexes display IR characteristics consistent
with an earlier report [8]. Full asignment of 1H and 13C chemical shifts, obtained in both CDCI3 and
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DMSO-d6 solutions, are listed in Tables 2 and 3. The assignments were based on the
interpretation of COSY, HSQC and HMBC methodologies. Interestingly, a solvent dependence
was found. Notably, in the 1H NMR spectra the positions of the chemical shifts due to H4 and H5
nuclei were variable as were the C3-C6 resonances in the 13C NMR spectra.
Figure displays major solvent dependence in the chemical shift of H6 in the spectra of
[Cy3PAu(2mba)], with only minor solvent dependence observed for H3-H5. In 100 % CDCI3, Figure
l(a), H6 appears downfield at 8.32 ppm due to anisotropy of the adjacent carbonyl -bond.
However, in 100 % DMSO-d6, Figure l(g), H6 is shifted upfield to 7.36 ppm, a shift of almost
ppm. This dramatic shift was proven by the gradual titration of DMSO-d6 into a CDCl3 solution of
[Cy3PAu(2mba)] as shown in spectra Figure l(b) -l(f). This dramatic shift could be caused by a
conformational flip of the -CO2H group induced by introduction of polar DMSO-d6 into the solvation
sphere of the [Cy3PAu(2mba)] molecule. Figure 2 shows the proposed structures of
[Cy3PAu(2mba)] in 100 % CDCl3 (a) and 100 % DMSO-d6 (b).
In CDCI3 (a), the anisotropic effects of the carbonyl -bond are facilitated by the intramolecular
O-H...S hydrogen bonding locking the -CO2H moiety into position. The ppm shift clearly indicates
that this orientation does not also exist in DMSO-d6, i.e. H6 is no longer in the deshielding region of
the carbonyl -bond. The polar DMSO-d6 molecules must disrupt the intramoleculr hydrogen
bonds with the formation of Q-H...DMSO-d6 intermolecular hydrogen bonds facilitated by bond
rotation around the C-C bond joining the phenyl ring to the -CO2H moiety, as shown in Figure 2 (b).
This bond rotation may also facilitate a weak Au...O contact as there is no evidence of a
conformational flip for 2mba with only a 0.21 ppm solvent dependant shift of H6 observed.
However, the possibility of a weak Au...O interaction is difficult to investigate as 197Au (100%
abundance) is not a suitable isotope to probe the structure of gold complexes.
TABLE 3. 130 NMR spectra (5 in ppm, coupling constants, in Hertz, are given in parentheses)
recorded in CDCI3 and DMSO-d6 solutions for 2mbaH and R3PAu(2mba). Abbreviation: d
doublet. Atom labels as for Table 2.
2mbaH Et Ph Cy
CDCI3 DMSO-d6 CDCI3 DMSO-d6 CDCI3 DMSO-d6 CDCI3 DMSO-d6
C1 124.8 126.5 131.4 135.6 131.3 135.7 131.1 135.3
C2 139.3 138.1 139.0 142.4 138.7 141.2 139.5 142.4
C3 131.1 130.9 137.4 134.8 137.5 135.1 137.2 134.5
C4 133.3 132.4 131.4 128.9 131.5 129.0 131.2 128.6
C5 124.8 124.6 125.5 122.9 125.7 123.1 125.3 122.7
C6 132.7 131.4 133.0 128.5 133.1 128.4 133.0 128.5
C=O 171.5 167.6 168.2 169.8 168.2 169.7 168.1 169.4
Cx 17.8 d 17.8 d 128.7 d 128.9 d 33.2 d 32.4 d
(58.4) (55.9) (28.1) (28.9)
C[ 8.9 8.9 134.1 d 133.8 d 26.9 d 26.3 d
(13.7) (13.6) (12.1) (12.0)
Cy 129.3 d 129.6 d 30.8 30.3
(11.4) (11.2)
C 132.0 d 132.0 d 25.7 25.4
(2.6) (2.2)
Since the 1H resonances of the 2mba ligand of the three R3PAu(2mba) complexes are very
similar in CDCI3 and also in DMSO-d6, it is concluded that Et and Ph derivatives have similar solution
structures to that proposed [Cy3PAu(2mba)].
In CDCI3 solution the 31p NMR chemical shifts were 5 37.1, 37.6 and 58.2 ppm, respectively
and in DMSO-d6 solution they were 5 39.7, 38.2 and 57.5 ppm, respectively. These resonances
are in the range expected for complexes of this type [16]. Electrospray mass spectroscopic
analysis in the negative ion mode revealed [M-H]-in each case. For R Et, the relative abundance
was 48 % and for the remaining complexes this ion was the only ion present.
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8.4 8.Z 8.0 7.8 7.5 7.4 7.Z ppm
Figure 1. The aromatic region of 300 MHz H spectra of [Cy3PAu(2mba)] in 100 % CDCI3 (a); in
CDCI3/DMSO-d6 mixtures of 4001:501 (b), 400Ltl:100JLtl (C), 400;ul:200pl (d), 4001:3001
(e), 4001.L1:400#1 (f); and in 100 % DMSO-d6
The spectrum for the R Et complex also showed a m/e at 503 which was assigned to [Au(2mba)2]-
(100 %). For the R Ph and Cy complexes a peak at 249 (91% and 49 %, respectively) was
assigned to [(2mba)Au(2mba-H)]2". In the positive mode, only ions were found in the spectrum of
the R Et complex with the major ions, i.e. m/e 783, assigned to [2mba(AuPEt3)2]+ (100 %) and
m/e 433, assigned to [Au(PEt3)2]+ (24 %). Crystals for the R Ph complex were obtained and
hence, an X-ray crystal structure analysis was performed.
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H6 0
0
PR3
(a) CDCI3
H6 0/H
,O---S,,,
CD3
CD3
u--.PR3
(b) d6-DMSO
Figure 2. Proposed solution structures of [Cy3PAu(2mba)] in CDCI3 and DMSO-d6 solution.
C26
C21
C3
P1 $2 C4
C
Cll C1 C6
02
s
Figure 3. The molecular structure of [Ph3PAu(2mba)] showing the association between
centrosymmetrically related molecules
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Molecular structure of [Ph3PAu(2mba)]
The molecular structure of [Ph3PAu(2mba)].is illustrated in Figure 3 and selected interatomic
parameters are collected in Table 3.
The gold atom exists in an almost linear geometry defined by a sulfur atom derived from the 2mba
anion and the phosphorus atom; S--Au--P is 173.1(1). The Au--S and Au--P distances of
2.298(3) ,& and 2.269(3) A, respectively are comparable to the equivalent distances of 2.313(1)
and 2.271(1) A, respectively found in the R Cy analogue [8]. As can be noted from Figure the
carboxyl residue is orientated so as to place the carbonyl O(1) atom in close proximity to the gold
atom. The Au...O(1) separation of 3.193(8) A is close to the sum of the van der Waals radii of these
atoms of 3.20 ,&, [17] and thus, does not represent a significant bonding interaction. The 2mba
ligand is not planar as seen in the C(2)/C(1)/C(1’)/O(1) torsion angle of 37(2). Further twisting
about the C(1 )--C(1’) bond could result in a tighter interaction between the gold and O(1) atoms,
however, this would result is less effective intermolecular interactions in the lattice. In the lattice,
the familiar carboxylate dimer configuration is found such that H(20)...O(1 )i is 1.65/, O(1 )...O(2) is
2.61(1) A and O(2)--H(20)...O(1) is 172, i.e. R(8) [18], (symmetry operation i:-x,-y, l-z). There
are no Au...Au contacts less than 6.0 A in the I,ttice. Interestingly, in the R Cy structure [8], an
alternative conformation of the 2mba ligand is found such that the carboxyl residue is directed away
from the gold centre and is best described as adopting an exo conformation as opposed to a endo
conformation as for the R Ph structure; see Figure 4.
Ph3P---Au
HO2C
Cy3P’-Au S
CO2H
Figure 4. Alternate conformations found in the R3PAu(2mba) molecules in the solid state as
established by X-ray crystallography
TABLE 3. Selected interatomic parameters (/, deg.) for [Ph3PAu(2mba)]
Au--S(2) 2.298(3) Au---P(1) 2.269(3)
S(2)--C(2) 1.77(1) P(1)---C(11) 1.83(1)
P(1)--C(21) 1.80(1) P(1)--C(31) 1.83(1)
S(2)--Au--P(1).
Au--P(1 )--C(11
Au--P(1 )---C(31)
C(11)--P(1)--C(31)
173.1 (1) Au---S(2)--C(2) 110.5(3)
114.8(3) Au---P(1 )--C(21) 112.0(3)
113.7(3) C(11)--P(1 )---C(21) 107.0(5)
103.0(5) C(21 )--P(1)--C(31) 105.5(5)
The effect on the gold atom geometry of the intramolecular Au...O(1) interaction in the R Ph
structure is minimal with the major influence being a greater distortion from linearity, i.e. S--Au--P is
173.1(1) cf.176.8(1) for the R Cy complex. Allied with the weak nature of the Au...O(1)
interaction is the expansion of Au---S(2)--C(2) angle to 110.5(3) cf. 102.8(1); a contraction of the
Au--S(2)--C(2) angle would result in a closer Au...O(1) interaction. Similar variations in structure
have been reported for related R3PAu(S2COR’) structures for which the behaviour was rationalised
in terms of steric interference/optimal crystal packing rather than electronic effects associated with
the phosphine ligands [19,20].
Antitumour Testing
The cytotoxicity of the R3PAu(2mba), R Et, Ph and Cy, complexes was tested in vitro
against seven well-characterised human tumour cell lines and the microculture sulforhodamine B
(SRB) test (see Experimental). Results are listed in Table 4. The R3PAu(2mba), R Et, Ph and Cy,
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complexes display a very high to a moderate cytotoxicity (ID50 < 250 ng/ml to 250- 2500 ng/ml).
Generally, amongst the gold complexes, the R Et derivatives are the most active against the range
of cell lines tested and the R Ph complexes, the least active, however, the relatively small range of
ID5o values is noted. Notable is the observation that the gold complexes are significantly more
active than cisplatin against the A498 (renal cancer) and H226 (non-small cell lung cancer) cell lines.
Indeed, the gold complexes were more active than any of the doxorubicin, cisplatin, 5-fluorouracil,
methotrexate and etoposide drugs against the H226 cell line. This result may indicate some
selectivity in activity and it will be of some interest to determine whether the observed in vitro activity
is maintained in vivo.
TABI..15 4. In vitro ID50 values (ng/ml) for the R3PAu(2mba), R Et, Ph and Cy, complexes and
new data for some established cytotoxic drugs: doxorubicin (DOX), cisplatin (CPT),
5-fluorouracil (5-FU), methotrexate (MTX) and etoposide (ETO)
Compound cell line
MCF7 EVSA-T WIDR IGROV M19 MEL A498 H226
R Et 405 110 984 43 118 65 69
R=Cy 411 225 772 182 292 95 97
R Ph 791 356 982 117 298 151 173
DOX 0 8 60 6 90 99
CPT 699 422 967 69 558 2253 3269
5-FU 750 475 225 297 442 43 340
MTX 8 5 <3 7 23 37 2287
ETO 2594 31 7 50 580 505 31 4 3934
The cell lines mentioned in this contribution have been used extensively in the analysis of
the cytotoxicity of various organotin compounds [e.g. 21 23 and see review [24]. It is pertinent to
note that, often, the in vitro activity of the studied organotin compounds is much greater than that
displayed by the R3PAu(2mba) complexes described herein.
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Note Added in Proof
During the final preparation of this paper, a related paper reporting some NMR work and the X-ray
crystal structure of [Ph3PAu(2mba)] appeared [25].
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